NPPA exempts Torrent Pharma Tapentadol Nasal Spray from price cap for 5 years Medical Dialogues Team5 July 2021 1:05 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has granted a rare exemption from price cap to Torrent Pharmaceuticals' Tapentadol...
22 drug samples including Sun Pharma Rosuvas fail to qualify CDSCO test Medical Dialogues Team4 July 2021 11:30 AM ISTSun Pharma clarified that two batches of Rosuvas 20 were found spurious
One Time Rise: NPPA approves 50 percent price hike for Carbamazepine, Ranitidine, Ibuprofen Medical Dialogues Team3 July 2021 10:55 AM ISTNew Delhi: Through a recent gazette notification, the National Pharmaceutical Pricing Authority (NPPA) has allowed a one-time hike of 50 per cent in...
WHO releases list of priority medical devices for diabetes, cardiovascular diseases management, Details Medical Dialogues Team2 July 2021 5:48 PM ISTNew Delhi: In order to aid policymakers and health-care providers in prioritizing the selection and procurement of medical devices for cardiovascular...
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 5:23 PM ISTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
NPPA alleges overcharging for cancer drug Tagrisso: AstraZeneca moves Delhi HC against Rs 157 crore demand notice Medical Dialogues Team30 Jun 2021 5:02 PM ISTNew Delhi: AstraZeneca Pharma India has moved the Delhi High Court challenging a demand notice issued by the National Pharmaceutical Pricing Authority...
DoP directs NPPA to fix price of Darunavir, Ritonavir for Emcure Pharma Medical Dialogues Team29 Jun 2021 5:09 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), has recently directed the National Pharmaceuticals Pricing Authority (NPPA) to fix the retail...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
IPCA Lab gets CDSCO panel nod for phase 3 trial of HCQ as add-on therapy in type 2 diabetes Medical Dialogues Team27 Jun 2021 11:30 AM ISTNew Delhi: IPCA Laboratories has secured the Central Drugs Standard Control Organization (CDSCO) panel nod to conduct a Phase III clinical trial of...
JB Chemicals and Pharmaceuticals launches Nintedanib for treatment in Idiopathic Pulmonary Fibrosis (IPF) Meghna A Singhania26 Jun 2021 11:06 AM ISTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. today announced the launch of 'Nintabid' Capsules containing Nintedanib 100mg and 150mg, an oral...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Mankind Pharma Medical Dialogues Team25 Jun 2021 5:22 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, Dapagliflozin to consumers, the National Pharmaceutical Pricing...
Sun Pharma gets CDSCO panel ok for BE study of Sitagliptin, Metformin, Glimepiride FDC Medical Dialogues Team24 Jun 2021 4:52 PM ISTNew Delhi: Pharmaceutical major, Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
